Robert Thomas, MD
Pain Medicine · Vestavia, ALNPI 1134339799
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 114 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations.
Across 114 payments — averaging $18.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Scilex Pharmaceuticals Inc.$462
- AbbVie$355
- Abbott$138
- MDD US Operations, LLC$116
- Pfizer$113
- Assertio Therapeutics, Inc.$107
- plus $776 from 20 others
What the payments were for
- Food & beverage$2,067100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Scilex Pharmaceuticals Inc. | 29 | $462 |
| AbbVie(2 entities) | 17 | $355 |
| Abbott | 7 | $138 |
| MDD US Operations, LLC | 9 | $116 |
| Pfizer | 7 | $113 |
| Assertio Therapeutics, Inc. | 6 | $107 |
| Amgen | 5 | $90 |
| Medtronic(2 entities) | 2 | $84 |
| Collegium Pharmaceutical, Inc. | 6 | $80 |
| Zyla Life Sciences, Inc. | 4 | $63 |
| Biotronik NRO, Inc. | 2 | $58 |
| Indivior Inc. | 2 | $45 |
| Vertex | 2 | $43 |
| Novartis | 2 | $35 |
| Redhill Biopharma Inc. | 2 | $32 |
| Spinal Simplicity, LLC | 2 | $31 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $30 |
| Iovance Biotherapeutics, Inc. | 1 | $26 |
| Averitas Pharma Inc. | 1 | $25 |
| Almatica Pharma LLC | 1 | $24 |
| Lundbeck LLC | 1 | $22 |
| Pacira Therapeutics, Inc. | 1 | $22 |
| IBSA Pharma Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Biodelivery Sciences International, Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $14 |
How this compares
$2,067 in reported general payments places this provider in the 55th percentile of 77 pain medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pain medicine in Vestavia
- Erin MorellaVestavia$3K
- Rachel RobertsVestavia$3K
- Christopher PaulBirmingham$64K
- Michael CosgroveHuntsville$25K
- Ron PitkanenMountain Brk$16K
- Elliott PenningtonDaphne$15K
- James ThackerHuntsville$13K
- Grant StoneMobile$11K
- Hayden HundleyDothan$11K
- Hugh MaddoxAnniston$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.